clinical trials

Association Between Ward-Specific Antimicrobial Use Density and Methicillin-Resistant Staphylococcu Aureus Surveillance: A 60-Month Study.

Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcu aureus surveillance: a 60-month study.

Infect Drug Resist. 2013; 6: 59-66
Yoshida J, Kikuchi T, Matsubara N, Asano I, Ogami N

It is not known whether or not ward-specific antimicrobial… Continue reading →

Examining the Effect of Teleconferences on Oncology Phase 1 Trials.

Examining the effect of teleconferences on oncology phase 1 trials.

J Cancer. 2013; 4(6): 464-7
McKane A, Sima C, Fleck S, Weiss GJ

Objective: Phase 1 clinical trials are the first stage of clinical development of an investigational agent.… Continue reading →

Morphological Patterns of Indirect Choroidal Rupture on Spectral Domain Optical Coherence Tomography.

Morphological patterns of indirect choroidal rupture on spectral domain optical coherence tomography.

Clin Ophthalmol. 2013; 7: 1503-9
Nair U, Soman M, Ganekal S, Batmanabane V, Nair K

To evaluate the morphological types of indirect choroidal rupture (ICR) using spectral… Continue reading →

Corrosive Oesophageal Injuries: A Preventable Menace.

Corrosive oesophageal injuries: a preventable menace.

Pan Afr Med J. 2013; 15: 11
Adedeji TO, Tobih JE, Olaosun AO, Sogebi OA

Potentially catastrophic presentations and lifelong complications resulting from corrosive ingestions in humans is one of the most challenging… Continue reading →

Mechanisms of Resistance to Sorafenib and the Corresponding Strategies in Hepatocellular Carcinoma.

Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma.

World J Hepatol. 2013 Jul 27; 5(7): 345-52
Zhai B, Sun XY

Sorafenib, the unique drug as first-line treatment for advanced hepatocellular carcinoma (HCC), has opened a… Continue reading →

Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Nano Today. 2013 Jun 1; 8(3): 313-331
Ma P, Mumper RJ

Anthracyclines (doxorubicin, daunorubicin, and idarubicin) are very effective chemotherapeutic drugs to treat many cancers; however, the development… Continue reading →

Antiproliferative Activity of New Benzimidazole Derivatives.

Antiproliferative activity of new benzimidazole derivatives.

Acta Biochim Pol. 2013 Jul 25;
B?aszczak-?wi?tkiewicz K, Olszewska P, Mikiciuk-Olasik E

A series of new benzimidazole derivatives were synthesized and tested in vitro for possible anticancer activity. Their effect of proliferation into… Continue reading →

Opportunities for Reversible Inhibitors of Monoamine Oxidase-a (RIMAs) in the Treatment of Depression.

Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression.

CNS Spectr. 2012 Sep; 17(3): 107-20
Lum CT, Stahl SM

Treatment-resistant depression (TRD) may be implicated in 33–57% of depression cases. The currently available effective treatments… Continue reading →

Vibration and Pressure Wave Therapy for Calf Strains: A Proposed Treatment.

Vibration and pressure wave therapy for calf strains: a proposed treatment.

Muscles Ligaments Tendons J. 2013 Apr; 3(2): 60-2
Saxena A, St Louis M, Fournier M

Calf (lower leg) strains have a variety of treatment regimens with variable outcomes… Continue reading →

“My Body’s a 50 Year-Old but My Brain Is Definitely an 85 Year-Old”: Exploring the Experiences of Men Ageing With HIV-Associated Neurocognitive Challenges.

“My body’s a 50 year-old but my brain is definitely an 85 year-old”: exploring the experiences of men ageing with HIV-associated neurocognitive challenges.

J Int AIDS Soc. 2013; 16: 18506
Hopcroft L, Bester L, Clement D, Quigley A, Sachdeva… Continue reading →